Literature DB >> 6681687

Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children.

J S Christiansen, H Orskov, C Binder, K W Kastrup.   

Abstract

The time course of plasma growth hormone (hGH) levels following sc and im injection of hGH was studied in 12 children with growth hormone deficiency who had received long-term treatment with im injections of highly purified hGH. Also the spontaneous diurnal GH levels in 8 normal children of comparable age were recorded. Blood samples were obtained during 24 h after im and sc injections of 4 IU/m2 hGH and analysed for immunoreactive hGH. While a median peak value of 160 ng/ml (range 135 to 475 ng/ml) was obtained 2 h after im injection, sc injection resulted in a more sustained elevation reaching 41 ng/ml (range 32 to 51 ng/ml) at 6 h subsiding slowly with a median concentration of 15 ng/ml (range 5-24 ng/ml) persisting after 14 h. Gel chromatography demonstrated that the hGH immunoreactivity of blood samples obtained as late as 14 h after sc injection had unaltered molecular size. Seven of the patients were further studied after sc injection of 2 IU/m2 at 20.00 h instead of in the morning. A plasma profile was attained during the night which roughly approximated the average nocturnal plasma pattern of the normal children.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681687     DOI: 10.1530/acta.0.1020006

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

1.  Long-term GH treatment of GH-deficient adults: comparison between one and two daily injections.

Authors:  C Höybye; M Rudling
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 2.  Optimization of growth hormone therapy in growth hormone deficient children.

Authors:  S M De Muinck Keizer-Schrama
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

3.  The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children.

Authors:  M Bozzola; G Radetti; S Pagani; M Draghi; G Aimaretti; G Rondini
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

4.  Comparison of growth hormone releasing hormone therapy and growth hormone therapy in growth hormone deficiency.

Authors:  O Butenandt; B Staudt
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

5.  Effects of recombinant human growth hormone on donor-site healing in severely burned children.

Authors:  D N Herndon; R E Barrow; K R Kunkel; L Broemeling; R L Rutan
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

6.  Single dose and pulsatile treatment with human growth hormone in growth hormone deficiency.

Authors:  P J Smith; P J Pringle; C G Brook
Journal:  Arch Dis Child       Date:  1987-08       Impact factor: 3.791

7.  Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group.

Authors:  S De Muinck Keizer-Schrama; B Rikken; A Hokken-Koelega; J M Wit; S Drop
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.